开云体育
P. Yan
All authors
About
Publications While At 开云体育
selected publications
Journal Article
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide
.
Diabetic Medicine.
2011
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
.
Lancet (London, England).
2010
Contact
full name
P.
Yan
Quick Info
Publications
Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science